Showing results (41-50 of 148) with videos related to
Sort By:
Pageof 15
Anti-Cancer Drugs|December 20, 2021
Rovalpituzumab tesirine resistance: analysis of a corresponding small cell lung cancer and circulating tumor cell line pairBarbara Rath, Adelina Plangger, Dagmar Krenbek, et al.Investigational New Drugs|October 1, 2021
Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung CancerAdelina Plangger, Barbara Rath, Maximilian Hochmair, et al.Anticancer Research|February 29, 2024
BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell LinesClemens Lang, Sandra Stickler, Barbara Rath, et al.Anticancer Research|December 31, 2021
MUC1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell Lung CancerBettina Savarese-Brenner, Marlene Heugl, Barbara Rath, et al.Discover Oncology|September 1, 2022
Cytotoxicity of combinations of the pan-KRAS SOS1 inhibitor BAY-293 against pancreatic cancer cell linesAdelina Plangger, Barbara Rath, Sandra Stickler, et al.Life Sciences|September 4, 2020
Effects of metformin on adipose-derived stromal cell (ADSC) - Breast cancer cell lines interactionMaryana Teufelsbauer, Barbara Rath, Adelina Plangger, et al.Medical Oncology (Northwood, London, England)|February 12, 2022
Effects of metformin on human bone-derived mesenchymal stromal cell-breast cancer cell line interactionsMaryana Teufelsbauer, Clemens Lang, Adelina Plangger, et al.Translational Lung Cancer Research|July 14, 2022
Comparative characteristics of small cell lung cancer and Ewing's sarcoma: a narrative reviewGerhard HamiltonExpert Opinion on Biological Therapy|September 21, 2020
Avelumab: search for combinations of immune checkpoint inhibition with chemotherapyGerhard HamiltonCancers|July 10, 2014
Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) OxoplatinGerhard HamiltonPageof 15